Search

Your search keyword '"Camma, C."' showing total 29 results

Search Constraints

Start Over You searched for: Author "Camma, C." Remove constraint Author: "Camma, C." Topic carcinoma, hepatocellular Remove constraint Topic: carcinoma, hepatocellular
29 results on '"Camma, C."'

Search Results

1. Pattern of macrovascular invasion in hepatocellular carcinoma

2. Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma

3. Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials

4. Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

5. A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma

6. Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon

7. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

8. Surveillance for hepatocellular carcinoma with a 3-months interval in 'extremely high-risk' patients does not further improve survival

9. Systemic therapies for hepatocellular carcinoma: The present and the future

10. Monofocal hepatocellular carcinoma: How much does size matter?

11. Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

12. Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence

13. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease

14. Sicily Network for Liver Cancer: A Multidisciplinary Network Model for the Management of Primary Liver Tumors

15. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

16. Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis

17. Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study

18. Refining sorafenib therapy: lessons from clinical practice

19. Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma

20. Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma

21. Years of life that could be saved from prevention of hepatocellular carcinoma

22. Recurrence of hepatocellular carcinoma after liver transplantation: an update

23. Oxidative stress inhibits IFN-α-induced antiviral gene expression by blocking the JAK–STAT pathway

24. Prevention of Hepatocellular Carcinoma

25. High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance

26. Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib

27. Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study

28. The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approach

29. Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis

Catalog

Books, media, physical & digital resources